Literature DB >> 8256221

Clinical features of duodenal somatostatinomas.

T D O'Brien1, G Chejfec, R A Prinz.   

Abstract

BACKGROUND: Duodenal somatostatinomas are rare tumors that are often asymptomatic or present with local symptoms rather than with evidence of excess somatostatin production. To characterize the clinical presentation and management of these neoplasms we reviewed the course of four patients.
METHODS: The records of three men and one woman with duodenal somatostatinomas, who were treated between 1988 and 1992, are reviewed.
RESULTS: Three of the patients presented with vague gastrointestinal complaints, and one was free of symptoms. No patient had symptoms of somatostatinoma syndrome, nor did any have associated neurofibromatosis. Three patients were diagnosed after biopsy of a submucosal mass during upper endoscopy. Three patients with tumors that measured less than 2 x 2 cm underwent local resection. One patient with a large tumor and liver metastases underwent a Whipple's operation and resection of the liver lesions. Immunohistochemically all tumors predominantly contained somatostatin, although each had traces of other neuropeptides. All tumors contained psammoma bodies. Follow-up periods ranged from 1 to 4 years.
CONCLUSIONS: Duodenal somatostatinomas often appear with only local symptoms or are completely asymptomatic. Small tumors may be locally excised. Intraarterial methylene blue injection may help localize very small tumors during operation. Larger tumors, including those with localized metastases, should also be resected when possible.

Entities:  

Mesh:

Year:  1993        PMID: 8256221

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Massive upper gastrointestinal bleeding as a manifestation of somatostatinoma of the ampulla of vater.

Authors:  A Rios; J A Fernandez; J M Rodríguez; J A Lujan; E Martínez; P Parrilla
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

2.  Abdominal tumours and neurofibromatosis.

Authors:  A J Martin; R C Williamson
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

3.  Pancreatic and peripancreatic somatostatinomas.

Authors:  J M L Williamson; C C Thorn; D Spalding; R C N Williamson
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

4.  Two synchronous somatostatinomas of the duodenum and pancreatic head in one patient.

Authors:  Radoje B Colović; Slavko V Matić; Marjan T Micev; Nikica M Grubor; Henry Dushan Atkinson; Stojan M Latincić
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

5.  Incidental small ampullary somatostatinoma treated with ampullectomy 2 years after diagnosis.

Authors:  G Guercioni; C Marmorale; W Siquini; M Fianchini; A Fianchini; E Landi
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 6.  Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.

Authors:  Daniel Relles; Jennie Baek; Agnieszka Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

7.  Thirty-Year Survival with an Untreated Malignant Duodenal Somatostatinoma.

Authors:  Jan Ulfberg; Tibor Tot; Erik Wilander
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

8.  Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis.

Authors:  Traian Dumitrascu; Simona Dima; Vlad Herlea; Victor Tomulescu; Mihnea Ionescu; Irinel Popescu
Journal:  Langenbecks Arch Surg       Date:  2012-04-03       Impact factor: 3.445

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.